SCHEMBL31455709

SCHEMBL31455709

COC(=O)c1cc(C)c(C(=O)OC(C)(C)C)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.38
ALDH1A1 P00352 3/20 0.37
HTT P42858 1/20 0.37
PDGFRB P09619 2/20 0.36
FGFR1 P11362 2/20 0.36
PDGFRA P16234 2/20 0.36
FLT1 P17948 2/20 0.36
FGFR3 P22607 2/20 0.36
KDR P35968 2/20 0.36
KDM4E B2RXH2 2/20 0.36
PKM P14618 1/20 0.36
ATR Q13535 1/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 2/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
ATM Q13315 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455919 0.90 KDM4E (0.41) ALDH1A1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL1418414 0.88 PDGFRB (0.42) NOTUMALDH1A1PDGFRBFGFR1PDGFRA
SCHEMBL31710286 0.85 ALDH1A1 (0.41) ALDH1A1HTTMAPTTSHR
SCHEMBL23785506 0.83 ALDH1A1 (0.38) ALDH1A1HTTTSHR
SCHEMBL10260913 0.83 GABRG2 (0.36) ALDH1A1HTTSCN9A
SCHEMBL15543791 0.83 POLB (0.45) ALDH1A1KDM4EPKMATRHPGD
SCHEMBL364791 0.81 POLB (0.40) ALDH1A1HTTHPGDMAPTGAA
SCHEMBL31455679 0.80 NOTUM (0.41) NOTUMALDH1A1HTTPDGFRBFGFR1
SCHEMBL27890 0.79 KDM4E (0.43) NOTUMALDH1A1PDGFRBFGFR1PDGFRA
SCHEMBL19993672 0.79 MAPT (0.42) NOTUMALDH1A1KDM4EHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059562-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed